ArticleMolecular carcinogenesis2024

Drug-target Mendelian randomization revealed a significant association of genetically proxied metformin effects with increased prostate cancer risk.

Xiaohui Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.